Koppers Holdings Inc. · NYSE:KOP
Koppers — Q2 2015 Earnings Presentation
13 slides from Koppers's earnings presentation, Aug 6, 2015
Slide 1: Second Quarter 2015 Earnings Call
Second Quarter 2015 Earnings Call August 6, 2015
Slide 2: Forward Looking Statement
Forward Looking Statement Certain statements in this presentation are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and may include, but are not limited to, statements about sales levels, acquisitions, restructuring, profitability and anticip
Slide 3: Q2 Sales Positively Affected by Acquisitions
Q2 Sales Positively Affected by Acquisitions…. ($ in millions) 2
Slide 4: Q2 Adjusted EBITDA Positively Affected by Acquisitions but Negatively Affected by Oil
….and Q2 Adjusted EBITDA Positively Affected by Acquisitions but Negatively Affected by Oil ($ in millions) 3
Slide 5: Debt repayment on pace to meet $100-$125 million reduction goal
Debt repayment is on pace to meet goal of $100-$125 million reduction ($ in millions) 4
Slide 6: 2015 Guidance
2015 Guidance ) Nn Wu! KOPPER
Slide 7: Expectations for RUPS EBITDA Improvement Have Not Changed
Expectations for RUPS EBITDA Improvement Have Not Changed ($ in millions) 6
Slide 8: PC should improve by $50 million
PC should improve by $50 million ($ in millions) 7
Slide 9: CMC expected to be $20-$30 million lower driven by oil prices
CMC expected to be $20-$30 million lower driven by oil prices ($ in millions) 8
Slide 10: Year 2015 sales expected to be $1.7B
Year 2015 sales expected to be $1.7B ($ in millions) 9
Slide 11: 2015 Consolidated EBITDA expected to be in $165-175 million range
2015 Consolidated EBITDA expected to be in $165-175 million range ($ in millions) 10
Slide 12: Appendix
) Nn Wu! KOPPER Appendix 11
Slide 13: EBITDA Reconciliation
EBITDA Reconciliation ($ in millions) Quarters ended June 30 2015 2014 Net income $ 7.9 $ 0.7 Interest expense 12.9 6.6 Depreciation and amortization 17.7 9.7 Income taxes 5.4 5.6 Loss from discontinued operations 0.0 0.1 EBITDA 43.9 22.7 Unusual items impacting net income Impairment, restructuring